octohydroaminoacridine
Small moleculeexperimental
Clinical trial activity
2 trials · 4 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
2
Phase 3
1
Phase 4
0
Earliest trial started Jun 1, 2011 (NCT01569516)
Timeline
Indications
Studied for
Mechanism of action
- AcetylcholinesteraseINHIBITOR
ACHE inhibitor
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- octohydroaminoacridine
- octohydroaminoacridine
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT03283059 | Phase 3 | Aug 16, 2017 | Changchun Huayang High-tech Co., Ltd, Jiangsu Sheneryang High-tech Co., Ltd, Jiao Tong University |
| NCT01569516 | Phase 2 | Jun 1, 2011 | Beijing Bionovo Medicine Development Co., Ltd., Changchun Huayang High-tech Co., Ltd, Jiao Tong University |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (4)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Changchun Huayang High-tech Co., Ltd | For profit | 2 | 1 | 2 | 2011 |
| Jiao Tong University | Academic/Hospital | 2 | 1 | 2 | 2011 |
| Beijing Bionovo Medicine Development Co., Ltd. | For profit | 1 | 0 | 1 | 2011 |
| Jiangsu Sheneryang High-tech Co., Ltd | Government | 1 | 0 | 1 | 2017 |
4 organizations
Page 1 / 1